InhibitING entry into S phase and cell cycle progression.
Lady Davis Institute for Medical Research, McGill University, Montréal, Canada. olivier.binda@mail.mcgill.ca
Olivier
O
Binda
D002453:Cell Cycle / Q000502:physiology*; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000235:genetics / Q000378:metabolism; D005786:Gene Expression Regulation; D051548:Histone Acetyltransferases / Q000378:metabolism; D056284:Histone Deacetylase 1 / Q000378:metabolism; D018398:Homeodomain Proteins / Q000378:metabolism*; D000076023:Inhibitor of Growth Protein 1; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism*; D009687:Nuclear Proteins / Q000378:metabolism*; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*; D016196:S Phase / Q000502:physiology*; D025521:Tumor Suppressor Proteins / Q000378:metabolism*
D050759:Cyclin-Dependent Kinase Inhibitor p21; D018398:Homeodomain Proteins; C501503:ING1 protein, human; C444654:ING2 protein, human; D000076023:Inhibitor of Growth Protein 1; D047908:Intracellular Signaling Peptides and Proteins; D009687:Nuclear Proteins; D018160:Receptors, Cytoplasmic and Nuclear; D025521:Tumor Suppressor Proteins; D051548:Histone Acetyltransferases; D056284:Histone Deacetylase 1